Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs.
$2.71-2.87%
报价 2026-11-06
市值
$5.8M
EV
$-6.8M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -99.2%
$2.65$354.00
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
L2 2026-05-21全文 ↓尚未生成 L3 估值，没有三情景目标价。去生成估值 →
基本面判断
›数据时效
基于 2026-05-21 收盘价 $0.52 及 TTM 财报
›盈利指标失效
PE/EV/EBITDA 因净亏损与负 EBITDA 失去参考意义
›核心锚点
PS 0.07x 为当前唯一有效相对估值指标
历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Drug Manufacturers - Specialty & Generic| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| SBFMSunshine Biopharma, Inc. | $5.8M | -2.9% | – | 29.8% | – | – | – | |
| AYTUAytu BioPharma, Inc. | $19.9M | +1.1% | +30.7% | 66% | – | – | – | |
| QNTMQuantum BioPharma Ltd. | $13.5M | -0.2% | – | 0% | – | – | – | |
| BFRIBiofrontera Inc. | $12.3M | +2.5% | +14.7% | 82.8% | – | – | – | |
| SNOASonoma Pharmaceuticals, Inc. | $5.3M | +3.7% | +15.5% | 38.9% | – | – | – | |
| YCBDcbdMD, Inc. | $4.7M | +7.2% | +7.1% | 54.7% | – | – | – | |
| APUSApimeds Pharmaceuticals US, Inc | $4.1M | -0.9% | – | 0% | – | – | – | |
| GELSGelteq Limited Ordinary Shares | $4M | -3.4% | – | 100% | – | – | – | |
| AKANAkanda Corp. | $2M | -1.4% | – | -160.1% | – | – | – | |
| 同行中位数 | – | – | +15.1% | 46.8% | – | – | – |
研究全文
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。